Infectious Disease· Topic 7.5 Lower respiratory tract infections· 7.5.4

Hospital-acquired pneumonia

Hospital-acquired pneumonia is a new pulmonary infiltrate with clinical signs of infection developing 48 hours or more after admission in a nonintubated patient, driven by gram-negative bacilli and Staphylococcus aureus rather than typical community organisms; empiric therapy is broad-spectrum antipseudomonal coverage started without delay and narrowed at 48 to 72 hours.

10 min read17 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    A new nosocomial pulmonary infection, not the community pathogen set: hospital-acquired pneumonia (HAP) is pneumonia developing in a nonintubated patient more than 48 hours after hospital admission…

  • Epidemiology

    Timing, not location, defines the diagnosis: HAP develops 48 hours or more after admission, excluding infections incubating at admission (Legionella has a 2- to 10-day incubation period and can…

  • Risk factors

    Intravenous antibiotic exposure within the past 90 days: the main risk factor for MRSA, resistant Pseudomonas, or other MDR pathogens, and the key trigger for broadening empiric coverage.

  • Pathophysiology

    Microaspiration of nosocomial-flora-colonized secretions: hospitalization shifts oropharyngeal and gastric colonization from community organisms to gram-negative bacilli and S.

  • Clinical features

    New or progressive infiltrate plus at least one sign of infection: fever above 38 degrees C (100.4 degrees F), leukocytosis or leukopenia, purulent sputum, or a decline in oxygenation.

  • Differential diagnosis

    Ventilator-associated pneumonia: the same syndrome but occurring more than 48 hours after endotracheal intubation; distinguished purely by intubation status and timing.

  • Diagnosis

    HAP is diagnosed by a new lung infiltrate plus clinical signs of lower respiratory infection, with no formal scoring system required: established when a new or progressive infiltrate is accompanied…

  • Management

    First, obtain lower respiratory and blood cultures, then start empiric antimicrobial therapy without waiting for results, because delay raises morbidity and mortality.

  • Complications

    Septic shock, requiring vasopressor support and fluid resuscitation per the sepsis pathway.

  • Prognosis

    A serious complication develops in about 50% of patients (respiratory failure, pleural effusion, septic shock, empyema, or kidney injury), making HAP a high-morbidity diagnosis.

  • Prevention

    Elevate the head of the bed to 30 to 45 degrees rather than supine, particularly for patients on enteral nutrition, who have the highest aspiration risk when supine.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.